Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

A cost-effectiveness analysis of South Africa's COVID-19 vaccination programme.

Edoka I. et al, (2024), Vaccine

Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization.

Shattock AJ. et al, (2024), Lancet (London, England), 403, 2307 - 2316

Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 26 February-1 March 2024.

Lambach P. et al, (2024), Vaccine, 42, 3379 - 3383

Strengthening health policy modelling in Africa.

Thumbi SM. et al, (2024), The Lancet. Global health, 12, e555 - e556

The Full Value of Vaccine Assessments Concept-Current Opportunities and Recommendations.

White RG. et al, (2024), Vaccines, 12

Modelling the Cost-Effectiveness of Hepatitis A in South Africa.

Patterson J. et al, (2024), Vaccines, 12

Mobilizing resources with an investment case to mitigate cross-border malaria transmission and achieve malaria elimination in South Africa.

Kollipara A. et al, (2023), Global health action, 16

Differential in-hospital mortality and intensive care treatment over time: Informing hospital pathways for modelling COVID-19 in South Africa.

Jamieson L. et al, (2023), PLOS global public health, 3

The National COVID-19 Epi Model (NCEM): Estimating cases, admissions and deaths for the first wave of COVID-19 in South Africa.

Silal SP. et al, (2023), PLOS global public health, 3

The role of modelling and analytics in South African COVID-19 planning and budgeting.

Meyer-Rath G. et al, (2023), PLOS global public health, 3

Seasonal targeting of the RTS,S/AS01 malaria vaccine: a complementary tool but sustained funding is required.

Silal SP., (2022), The Lancet. Global health, 10, e1693 - e1694

COVID-19 response in South African communities: Screening, testing, tracing and movement modelling.

Modisenyane M. et al, (2022), South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 112, 366 - 370

Leveraging epidemiology as a decision support tool during the COVID-19 epidemic in South Africa

Silal SP. et al, (2022), SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 112, 361 - 365

A retrospective study assessing the clinical outcomes and costs of acute hepatitis A in Cape Town, South Africa.

Patterson J. et al, (2022), BMC infectious diseases, 22

Assessing the effectiveness of malaria interventions at the regional level in Ghana using a mathematical modelling application.

Awine T. and Silal SP., (2022), PLOS global public health, 2

Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelines.

Pollett S. et al, (2021), PLoS medicine, 18

Investment case for malaria elimination in South Africa: a financing model for resource mobilization to accelerate regional malaria elimination.

Njau J. et al, (2021), Malaria journal, 20

Operational research: A multidisciplinary approach for the management of infectious disease in a global context.

Silal SP. and Modelling and Simulation Hub, Africa (MASHA) None., (2021), European journal of operational research, 291, 929 - 934

The Role of Remdesivir in South Africa: Preventing COVID-19 Deaths Through Increasing Intensive Care Unit Capacity.

Nichols BE. et al, (2021), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 72, 1642 - 1644

Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa

Jo Y. et al, (2021), Open Forum Infectious Diseases, 8

Load More

Include forthcoming?